Quantitative phosphoproteomic analyses identify STK11IP as a lysosome-specific substrate of mTORC1 that regulates

Zhenzhen Zi1, Zhuzhen Zhang2, Qiang Feng3

  • 1Department of Biochemistry, University of Texas Southwestern Medical Center, Dallas, TX, 75390, USA.

Nature Communications
|April 2, 2022
PubMed

Insights

The mechanistic target of rapamycin complex 1 (mTORC1) phosphorylates STK11IP on lysosomes, inhibiting autophagy. STK11IP dephosphorylation activates autophagy, offering a therapeutic target for metabolic diseases.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Metabolism

Background:

  • The serine/threonine kinase mTORC1 regulates cell growth and proliferation, and is activated on lysosomal surfaces.
  • The precise role of mTORC1 in phosphorylating local lysosomal proteins to control lysosomal biology remains unclear.

Purpose of the Study:

  • To investigate whether mTORC1 phosphorylates lysosomal proteins to regulate lysosomal biology.
  • To identify lysosome-specific substrates of mTORC1 and elucidate their function.

Main Methods:

  • Cross-reference analysis of lysosome proteome and mTORC1-regulated phosphoproteome.
  • STK11IP knockout and dephosphorylation studies in mice.
  • V-ATPase activity assays.

Main Results:

  • STK11IP was identified as a lysosome-specific substrate of mTORC1, phosphorylated at Ser404.
  • STK11IP knockout significantly increased autophagy flux.
  • STK11IP binds to and regulates V-ATPase activity, impacting lysosomal acidification and autophagy.
  • STK11IP knockout protected mice against fatty liver induced by fasting or a methionine/choline-deficient diet.

Conclusions:

  • STK11IP phosphorylation by mTORC1 is a novel mechanism regulating lysosomal acidification and autophagy.
  • STK11IP acts as an autophagy inhibitor, and its dephosphorylation at Ser404 represses this function.
  • Targeting STK11IP offers a potential therapeutic strategy for diseases characterized by dysregulated autophagy.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
4.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
13.5K